Concord Biotech Limited — Important, 22-07-2025: Updates

Concord Biotech has established Concord Lifegen Limited, a new wholly-owned subsidiary with an initial capitalisation of Rs. 0.01 Cr. This strategic move aims to fortify the company's marketing, sales, and distribution capabilities for pharmaceutical products. The new entity will drive targeted sales strategies, ensure robust regulatory compliance across markets, and boost customer engagement. This is a key business development positioning Concord Biotech for enhanced commercial efficiency and stronger market reach within the biopharmaceutical sector.